Product
PegIFN-alpha-2a
Aliases
PegIFN-alpha-2a (Optional)
3 clinical trials
2 indications
Indication
Hepatitis BIndication
ChronicClinical trial
A Phase 2, Randomized, Open-label, Multicenter Study to Evaluate Efficacy, Pharmacokinetics, Safety, and Tolerability of Treatment With JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog With or Without JNJ-56136379 in Treatment-naive Patients With HBeAg Positive Chronic Hepatitis B Virus InfectionStatus: Completed, Estimated PCD: 2023-08-29
Clinical trial
A Phase 2 Randomized, Open-label, Parallel-group, Multicenter Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Response to Combination Regimens Containing JNJ-73763989 and Nucleos(t)Ide Analog With or Without JNJ-56136379 in Patients With Chronic Hepatitis B Virus InfectionStatus: Completed, Estimated PCD: 2023-02-08
Clinical trial
A Phase 2, Open-label, Multicenter Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Treatment With JNJ-73763989, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Patients With Chronic Hepatitis B Virus InfectionStatus: Terminated, Estimated PCD: 2021-12-29